exact differences between TCI and closed loop anesthesia drug delievery system
TCI vs closed loop anesthesia drug delivery system differences
closed loop anesthesia drug delivery TCI comparison
differences between TCI and closed loop anesthesia drug delivery
"closed-loop" AND anesthesia AND "target-controlled infusion"
| Feature | TCI (Target-Controlled Infusion) | Closed-Loop Delivery System |
|---|---|---|
| System type | Open-loop | Closed-loop (feedback control) |
| Feedback | None - no measurement of drug effect | Real-time measurement of drug effect feeds back to controller |
| What drives dosing | Population-derived PK/PK-PD mathematical models | Measured patient response (BIS, NMT, hemodynamics, etc.) |
| Clinician role | Sets a target concentration; system calculates infusion rate | Sets a target effect level (e.g., BIS 40-60); system auto-adjusts |
| Basis of delivery | Predicted concentration in plasma or effect-site | Actual observed pharmacodynamic effect |
"TCI relies on pharmacokinetic models that are based on the simplifying assumption of instantaneous and complete mixing within Vc. Overestimation of Vc results in plasma drug concentrations that overshoot the desired target concentration, especially in the first few minutes after beginning the infusion." - Barash, Clinical Anesthesia 9e, p. 815-816
"When a valid and nearly continuous measure of drug effect is available, drug delivery can be automatically titrated by feedback control... A target value for the desired effect measure (the output of the system) is selected and the rate of drug delivery (the input into the system) is dependent on whether the effect measure is above, below, or at the target value. Thus, the output feeds back and controls the input." - Barash, Clinical Anesthesia 9e, p. 816
| Parameter | TCI | Closed-Loop |
|---|---|---|
| Feedback loop | Absent | Present (true feedback) |
| Control variable | Drug concentration (plasma or effect-site) | Drug effect (BIS, NMT, MAP, etc.) |
| Model dependency | Entirely model-dependent | Model-assisted or model-independent |
| PK model required | Yes - mandatory | Optional (some systems combine TCI + closed loop) |
| PD model required | Optional (for Ce targeting via ke0) | Yes - the measured PD output IS the feedback |
| Interpatient variability | Cannot correct for it | Automatically compensates for it |
| Intraoperative changes | Cannot adapt (e.g., blood loss, cardiac output changes) | Continuously adapts in real-time |
| Controller | PK model only | PID controller / model-predictive / adaptive / AI |
| Feedback signal | None | BIS (hypnosis), NMT (neuromuscular blockade), MAP/CO (hemodynamics), blood glucose |
| Clinical applications | Propofol, remifentanil, sufentanil, dexmedetomidine TIVA | Propofol-BIS, rocuronium-NMT, vasopressors-MAP, insulin-glucose |
| Drug waste | Higher (model inaccuracies cause over-delivery) | Lower - superior titration efficiency |
| Time at target | Variable, model-dependent | Longer "time on target" vs TCI and manual |
| Emergence time | Standard | Faster and more consistent |
| Clinical evidence | Established, FDA/CE-cleared systems widely available | Superior performance demonstrated in RCTs; CLADS shows better depth maintenance than TCI propofol |
| Regulatory status | Commercially mature (Diprifusor, Orchestra, etc.) | Emerging; some systems FDA/CE cleared (e.g., SEDASYS - discontinued; MCAS; CLADS in India) |
| Clinician override | Sets target concentration; pump can be overridden | Sets target effect value; continuous automatic adjustment; clinician supervises |
| Risk of accumulation | Yes - if PK model underestimates clearance | Reduced - feedback prevents over-sedation |
Manual infusion → No model, no feedback
↓
TCI (open-loop) → PK model, no feedback (predicts concentration)
↓
TCI + PD model → PK+PD model, no feedback (predicts effect-site)
↓
Closed-loop → Measures actual effect, auto-adjusts infusion
↓
Hybrid closed-loop TCI → PK model + real-time effect feedback combined
does tci also facilitate BIS ?
"target controlled infusion" AND "bispectral index" AND propofol
"TCI is often combined with the use of the bispectral index (BIS) or other monitors of processed EEG signals... but target concentrations should be titrated to individual effect." - Katzung's Basic & Clinical Pharmacology, 16e
"Drugs were administered using TCI pumps programmed with the Schnider model for propofol... and clinical drug effect was measured using the bispectral index (BIS). They found a significant propofol effect-site concentration..." - Miller's Anesthesia, 10e
"The measured bispectral index (BIS) is used as the input of the closed-loop controller. The dotted lines represent the Bayesian sigmoid... The result of these calculations is the required effect-site concentration sent to the TCI algorithm, which steers the pump." - Miller's Anesthesia, 10e
| Scenario | BIS Role | System Type |
|---|---|---|
| TCI alone | Not used at all | Open-loop |
| TCI + BIS monitor (clinical practice) | Clinician reads BIS, manually adjusts target | Open-loop (human-in-the-loop) |
| BIS-guided closed-loop TCI | BIS electronically adjusts TCI target automatically | Closed-loop |
apnea test for brain death
"apnea test" AND "brain death" AND determination
| # | Prerequisite |
|---|---|
| 1 | Coma is irreversible and the cause is known |
| 2 | Neuroimaging explains the coma |
| 3 | Sedative/anesthetic drug effect is absent (toxicology screen if indicated) |
| 4 | No residual neuromuscular blocking agents (peripheral nerve stimulator if used) |
| 5 | Core body temperature ≥ 36°C (hypothermia causes reversible brainstem depression) |
| 6 | No severe acid-base, electrolyte, or endocrine disturbance |
| 7 | Systolic BP ≥ 100 mmHg (vasopressors used as needed) |
| 8 | Normal baseline PaCO2 (35-45 mmHg) - ensure normocapnia before starting |
"The main confounding factors that need to be excluded are hypothermia (core body temperature should be ≥36°C); drug intoxication or poisoning; lingering effects of sedatives, analgesics, and neuromuscular blockers; and severe electrolyte or acid-base disturbances." - Bradley and Daroff's Neurology in Clinical Practice
"The lack of respiratory drive is demonstrated when there have been no breathing efforts despite a rise in PaCO2 to 60 mm Hg or an increase of 20 mm Hg or greater from a normal baseline PaCO2." - Bradley and Daroff's Neurology in Clinical Practice
"The apnea test demonstrates no spontaneous breathing even when PaCO2 is allowed to rise above 60 mmHg." - Schwartz's Principles of Surgery, 11e
| Test | Findings in Brain Death |
|---|---|
| Cerebral angiography (gold standard) | No intracranial blood flow |
| Technetium radionuclide scan | No cerebral perfusion ("empty skull" sign) |
| Transcranial Doppler (TCD) | Reverberating/to-and-fro flow pattern - no net forward flow |
| EEG | Electrocerebral silence (< 2 μV for 30 min, ≥8 electrodes) - not preferred due to artifact |
| Auditory/Somatosensory evoked potentials | Absent central responses |
"Brain death is a clinical determination, and in the United States does not require additional ancillary tests in most cases." - Bradley and Daroff's Neurology in Clinical Practice